ADMA Biologics Inc
(NAS:ADMA)
$
11.14
0.13 (1.18%)
Market Cap: 2.58 Bil
Enterprise Value: 2.65 Bil
PE Ratio: 0
PB Ratio: 16.88
GF Score: 65/100 - Q4 2023 ADMA Biologics Inc Earnings Call TranscriptFeb 28, 2024$5.38 (-2.54%)Earnings
- Q3 2023 ADMA Biologics Inc Earnings Call TranscriptNov 08, 2023$3.62 (-1.90%)Earnings
- Q2 2023 ADMA Biologics Inc Earnings Call TranscriptAug 09, 2023$4.06 (-1.93%)Earnings
- Q1 2023 ADMA Biologics Inc Earnings Call TranscriptMay 10, 2023$3.57 (+2.88%)Earnings
- Q4 2022 ADMA Biologics Inc Earnings Call TranscriptMar 23, 2023$3.11 (+3.32%)Earnings
- Q3 2022 ADMA Biologics Inc Earnings Call TranscriptNov 09, 2022$2.47 (-5.36%)Earnings
- Q2 2022 ADMA Biologics Inc Earnings Call TranscriptAug 10, 2022$2.12 (+4.43%)Earnings
- Q1 2022 ADMA Biologics Inc Earnings Call TranscriptMay 11, 2022$1.43 (-11.18%)Earnings
- Q4 2021 ADMA Biologics Inc Earnings Call TranscriptMar 24, 2022$1.5 (+2.74%)Earnings
- Q3 2021 ADMA Biologics Inc Earnings Call TranscriptNov 10, 2021$1.4 (-1.41%)Earnings
- ADMA Biologics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 ADMA Biologics Inc Earnings Call TranscriptAug 11, 2021$1.53 (-0.65%)Earnings
- ADMA Biologics Inc Annual Shareholders Meeting TranscriptMay 27, 2021
- Q1 2021 ADMA Biologics Inc Earnings Call TranscriptMay 12, 2021$1.67 (-3.47%)Earnings
- Q4 2020 ADMA Biologics Inc Earnings Call TranscriptMar 25, 2021$2.05 (+3.54%)Earnings
- ADMA Biologics Inc at Jefferies Virtual Plasma Summit TranscriptMar 11, 2021
- Q3 2020 ADMA Biologics Inc Earnings Call TranscriptNov 05, 2020$2.11 (-1.40%)Earnings
- ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 ADMA Biologics Inc Earnings Call TranscriptAug 05, 2020$3.56 (+5.64%)Earnings
- Q1 2020 ADMA Biologics Inc Earnings Call TranscriptMay 06, 2020$3.2 (+0.95%)Earnings
- Q4 2019 ADMA Biologics Inc Earnings Call TranscriptMar 12, 2020$2.19 (-5.19%)Earnings
ADMA Biologics Inc at Jefferies Virtual Plasma Summit Transcript
Mar 11, 2021 / 04:20PM GMT
Release Date Price:
$2.16
(+1.89%)
Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst
Welcome everyone to the Jefferies First Annual Global Plasma Summit. With us up next, we have Adam Grossman and Brian Lenz, CEO and CFO of ADMA Biologics. We have 30 minutes allotted for a fireside chat session. So we look forward to the segment, and thank you both for joining us this year.
Brian Lenz
ADMA Biologics, Inc. - Executive VP & CFO
Thank you for having us.
Adam S. Grossman
ADMA Biologics, Inc. - Co-Founder, President, CEO & Director
Thank you very much, Anthony.
Questions & Answers
Anthony Charles Petrone
Jefferies LLC, Research Division - Healthcare Analyst
And maybe where we're starting off, Adam, is a little bit on a look back at 2020 and where we sit as of March, mid-March now we're approaching, it is the 1-year anniversary for most of COVID-19. So maybe a moment on how 2020 played out for ADMA and what are the most updated views as we sit here at the 1-year
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)